MaaT Pharma SA

EPA:MAAT.PA

7.78 (EUR) • At close November 12, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) EUR.

2023202220212020201920182017
Operating Activities:
Net Income -19.717-13.713-9.019-5.301-5.844-4.475-3.858
Depreciation & Amortization 0.8710.4290.3280.1640.0970.0790
Deferred Income Tax -0.56800.0010.002000
Stock Based Compensation 0.870.6520.7850.0150.0150.0090
Change In Working Capital -0.384-0.05-0.21-0.759-0.1610.4680
Accounts Receivables 0.346-0.321-0.854-0.38-0.3270.1550
Inventory -0.143-0.014-0.0330000
Accounts Payables 1.8412.0360.8540000
Other Working Capital -2.428-1.751-0.177-0.3790.1660.3130
Other Non Cash Items 0.7180.0770.1860.0650.8740.0483.858
Operating Cash Flow -18.21-12.605-7.929-5.814-5.019-3.8710
Investing Activities:
Investments In Property Plant And Equipment -1.093-0.662-0.238-0.316-0.128-0.2910
Acquisitions Net 0000000
Purchases Of Investments 0-0.1990-0.178000
Sales Maturities Of Investments 0.014000000
Other Investing Activites 0.6530.0460-0.029-0.026-0.020
Investing Cash Flow -1.079-0.815-0.238-0.523-0.154-0.3110
Financing Activities:
Debt Repayment -4.1935.55-0.4852.93600.4670
Common Stock Issued 12.5920.10232.43517.95300.0280
Common Stock Repurchased -0.079-0.13700000
Dividends Paid 0000000
Other Financing Activities -0.179-0.151-0.392-0.056.983-0.0630
Financing Cash Flow 8.325.36431.55820.8396.9830.4320
Other Information:
Effect Of Forex Changes On Cash 0.001-0.0010.00100.00100
Net Change In Cash -10.968-8.05723.39214.5021.811-3.750
Cash At End Of Period 24.2835.24743.30519.9135.4113.60